MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
Background: Micheliolide (MCL), which is the active metabolite of parthenolide, has demonstrated promising clinical application potential. However, the effects and underlying mechanisms of MCL on atherosclerosis are still unclear. Method: ApoE−/− mice were fed with high fat diet, with or without MCL...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2024-02-01
|
| Серии: | Redox Biology |
| Предметы: | |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S2213231723003889 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|